Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lina Posada

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Urology Practice|June 24, 2024
Surgical Outcomes and Genomic Insights of Nonclear Cell Renal Cell Carcinoma With Synchronous and Metachronous Nodal DiseaseLennert Eismann, Mark Zucker, Mark T Dawidek, et al.
Urology Practice|January 28, 2025
Higher Risk Renal Angiomyolipomas: Surveillance Remains a Safe Management OptionMark T Dawidek, Juan Sebastian Arroyave Villada, Katiana Vazquez-Rivera, et al.
European Journal of Human Genetics : EJHG|June 1, 2024
Benign splenic lesions in BAP1-tumor predisposition syndrome: a case seriesJoao Miranda, Priya Dave, Yelena Kemel, et al.
Cancers|December 11, 2025
Clinical and Molecular Characterization of KRAS-Mutated Renal Cell CarcinomaAndrea Lopez Sanmiguel, Yash S Khandwala, Kuo Fengshen, et al.
Scientific Reports|June 10, 2026
Natural language processing models for patient-centered summaries of prostatectomy pathology reportsParsa Iranmahboub, Priya Dave, Michael Hung, et al.
Urologic Oncology|May 21, 2026
Effective PD-1 checkpoint blockade in bladder cancer model requires tumor-draining lymph nodes and lymphocyte traffickingJuan C Angulo-Lozano, Lina Posada-Calderon, Huixian Liu, et al.
Plos One|December 10, 2019
Validation of risk factors for recurrence of renal cell carcinoma: Results from a large single-institution seriesJohannes C van der Mijn, Bashir Al Hussein Al Awamlh, Aleem Islam Khan, et al.
Urologic Oncology|September 12, 2025
Long-term oncologic outcomes of metastatic clear-cell renal cell carcinoma after local therapy aloneDaniel Barbakoff, Mark T Dawidek, Andrea Knezevic, et al.
BMJ Global Health|September 25, 2025
Safety and efficacy of the ShangRing for early infant male circumcision in the routine clinical settingLina Posada Calderon, Spyridon P Basourakos, Karla V Ballman, et al.
European Urology|November 5, 2025
MLH1 Mismatch Repair Deficiency Predicts Exceptional Response to Immune Checkpoint Inhibition in Clear-cell Renal Cell CarcinomaMark T Dawidek, Lina Posada Calderon, Parantu K Shah, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Urology Practice|June 24, 2024
Surgical Outcomes and Genomic Insights of Nonclear Cell Renal Cell Carcinoma With Synchronous and Metachronous Nodal DiseaseLennert Eismann, Mark Zucker, Mark T Dawidek, et al.
Urology Practice|January 28, 2025
Higher Risk Renal Angiomyolipomas: Surveillance Remains a Safe Management OptionMark T Dawidek, Juan Sebastian Arroyave Villada, Katiana Vazquez-Rivera, et al.
European Journal of Human Genetics : EJHG|June 1, 2024
Benign splenic lesions in BAP1-tumor predisposition syndrome: a case seriesJoao Miranda, Priya Dave, Yelena Kemel, et al.
Cancers|December 11, 2025
Clinical and Molecular Characterization of KRAS-Mutated Renal Cell CarcinomaAndrea Lopez Sanmiguel, Yash S Khandwala, Kuo Fengshen, et al.
Scientific Reports|June 10, 2026
Natural language processing models for patient-centered summaries of prostatectomy pathology reportsParsa Iranmahboub, Priya Dave, Michael Hung, et al.
Urologic Oncology|May 21, 2026
Effective PD-1 checkpoint blockade in bladder cancer model requires tumor-draining lymph nodes and lymphocyte traffickingJuan C Angulo-Lozano, Lina Posada-Calderon, Huixian Liu, et al.
Plos One|December 10, 2019
Validation of risk factors for recurrence of renal cell carcinoma: Results from a large single-institution seriesJohannes C van der Mijn, Bashir Al Hussein Al Awamlh, Aleem Islam Khan, et al.
Urologic Oncology|September 12, 2025
Long-term oncologic outcomes of metastatic clear-cell renal cell carcinoma after local therapy aloneDaniel Barbakoff, Mark T Dawidek, Andrea Knezevic, et al.
BMJ Global Health|September 25, 2025
Safety and efficacy of the ShangRing for early infant male circumcision in the routine clinical settingLina Posada Calderon, Spyridon P Basourakos, Karla V Ballman, et al.
European Urology|November 5, 2025
MLH1 Mismatch Repair Deficiency Predicts Exceptional Response to Immune Checkpoint Inhibition in Clear-cell Renal Cell CarcinomaMark T Dawidek, Lina Posada Calderon, Parantu K Shah, et al.
Pageof 4